Cargando…
Pharmacogenetics of Statin-Induced Myopathy: A Focused Review of the Clinical Translation of Pharmacokinetic Genetic Variants
Statins are the most commonly prescribed drugs in the United States and are extremely effective in reducing major cardiovascular events in the millions of Americans with hyperlipidemia. However, many patients (up to 25%) cannot tolerate or discontinue statin therapy due to statin-induced myopathy (S...
Autores principales: | Talameh, Jasmine A, Kitzmiller, Joseph P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160888/ https://www.ncbi.nlm.nih.gov/pubmed/25221728 http://dx.doi.org/10.4172/2153-0645.1000128 |
Ejemplares similares
-
Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects
por: Ramakumari, Nuthalapati, et al.
Publicado: (2018) -
Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
por: Camerino, Giulia Maria, et al.
Publicado: (2021) -
Pharmacogenetics of Statin-Induced Myotoxicity
por: Kee, Ping Siu, et al.
Publicado: (2020) -
Statin-induced Myopathy
por: Fitzgerald, Kara, et al.
Publicado: (2012) -
Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial
por: Vassy, Jason L., et al.
Publicado: (2020)